An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022127
Company: SANOFI

Summary Review

Products on NDA 022127

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RENVELA	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022127

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/19/2007	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022127lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022127s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022127s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022127s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/06/2023	SUPPL-21	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022127Orig1s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022127Orig1s021ltr.pdf
04/30/2020	SUPPL-19	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022127s019,022318s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022127Orig1s019,022318Orig1s012ltr.pdf
11/25/2016	SUPPL-15	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022127s015,022318s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022127Orig1s015, 022318Orig1s008ltr.pdf
03/09/2016	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022127s013,022318s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022127Orig1s013,022318Orig1s006ltr.pdf
11/26/2014	SUPPL-11	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022127s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022127Orig1s011,022318Orig1s005ltr.pdf
06/16/2011	SUPPL-8	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022318s003,022127s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021179s029,022127s008,022318s003ltr.pdf

Labels for NDA 022127

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/06/2023	SUPPL-21	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022127Orig1s021lbl.pdf
06/06/2023	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022127Orig1s021lbl.pdf
04/30/2020	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022127s019,022318s021lbl.pdf
11/25/2016	SUPPL-15	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022127s015,022318s008lbl.pdf
03/09/2016	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022127s013,022318s006lbl.pdf
11/26/2014	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022127s011lbl.pdf
06/16/2011	SUPPL-8	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022318s003,022127s008lbl.pdf
10/19/2007	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022127lbl.pdf

Therapeutic Equivalents for NDA 022127

RENVELA

TABLET;ORAL; 800MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
RENVELA	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	Yes	AB	022127	SANOFI
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	207288	AMNEAL PHARMS CO
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	200959	ARTHUR GRP
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	207179	AUROBINDO PHARMA
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	206094	DR REDDYS
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	203860	INVAGEN PHARMS
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	206100	MACLEODS PHARMS LTD
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	215537	MICRO LABS
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	204451	RISING
SEVELAMER CARBONATE	SEVELAMER CARBONATE	800MG	TABLET;ORAL	Prescription	No	AB	207759	ZYDUS PHARMS

Top